Stephen Robert Gregory - Net Worth and Insider Trading

Stephen Robert Gregory Net Worth

The estimated net worth of Stephen Robert Gregory is at least $719,398 dollars as of 2024-06-16. Stephen Robert Gregory is the Director of Acerus Pharmaceuticals Corp and owns about 1,994,627 shares of Acerus Pharmaceuticals Corp (TSX:ASP) stock worth over $718,066. Stephen Robert Gregory is also the Director of Adya Inc and owns about 20,500 shares of Adya Inc (TSXV:ADYA) stock worth over $1,333. Details can be seen in Stephen Robert Gregory's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen Robert Gregory has not made any transactions after 2022-03-15 and currently still holds the listed stock(s).

Transaction Summary of Stephen Robert Gregory

To

Stephen Robert Gregory Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Robert Gregory owns 2 companies in total, including Acerus Pharmaceuticals Corp (TSX:ASP) , and Adya Inc (TSXV:ADYA) .

Click here to see the complete history of Stephen Robert Gregory’s form 4 insider trades.

Insider Ownership Summary of Stephen Robert Gregory

Ticker Comapny Transaction Date Type of Owner
TSX:ASP Acerus Pharmaceuticals Corp 2018-12-24 Director
TSXV:ADYA Adya Inc 2022-03-15 Director

Stephen Robert Gregory Latest Holdings Summary

Stephen Robert Gregory currently owns a total of 2 stocks. Among these stocks, Stephen Robert Gregory owns 1,994,627 shares of Acerus Pharmaceuticals Corp (TSX:ASP) as of December 24, 2018, with a value of $718,066 and a weighting of 99.81%. Stephen Robert Gregory also owns 20,500 shares of Adya Inc (TSXV:ADYA) as of March 15, 2022, with a value of $1,333 and a weighting of 0.19%.

Latest Holdings of Stephen Robert Gregory

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ASP Acerus Pharmaceuticals Corp 2018-12-24 1,994,627 0.36 718,066
TSXV:ADYA Adya Inc 2022-03-15 20,500 0.07 1,333

Holding Weightings of Stephen Robert Gregory


Stephen Robert Gregory Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Robert Gregory has made a total of 0 transactions in Acerus Pharmaceuticals Corp (TSX:ASP) over the past 5 years. The most-recent trade in Acerus Pharmaceuticals Corp is the acquisition of 429,000 shares on December 24, 2018, which cost Stephen Robert Gregory around $9 Million.

According to the SEC Form 4 filings, Stephen Robert Gregory has made a total of 5 transactions in Adya Inc (TSXV:ADYA) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Adya Inc is the acquisition of 3,000 shares on March 15, 2022, which cost Stephen Robert Gregory around $465.

Insider Trading History of Stephen Robert Gregory

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Robert Gregory Trading Performance

GuruFocus tracks the stock performance after each of Stephen Robert Gregory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen Robert Gregory is -5.09%. GuruFocus also compares Stephen Robert Gregory's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen Robert Gregory within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen Robert Gregory's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen Robert Gregory

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.28 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -20.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephen Robert Gregory Ownership Network

Ownership Network List of Stephen Robert Gregory

No Data

Ownership Network Relation of Stephen Robert Gregory

Insider Network Chart

Stephen Robert Gregory Owned Company Details

What does Acerus Pharmaceuticals Corp do?

Who are the key executives at Acerus Pharmaceuticals Corp?

Stephen Robert Gregory is the Director of Acerus Pharmaceuticals Corp. Other key executives at Acerus Pharmaceuticals Corp include Director & Senior Officer Edward Joseph Gudaitis , and Senior Officer Robert Martin Motz .

Acerus Pharmaceuticals Corp (TSX:ASP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acerus Pharmaceuticals Corp (TSX:ASP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acerus Pharmaceuticals Corp Insider Transactions

No Available Data

Stephen Robert Gregory Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Robert Gregory. Currently GuruFocus does not have mailing address information for Stephen Robert Gregory.

Discussions on Stephen Robert Gregory

No discussions yet.